Anteris Technologies Global Corp. Common Stock
AVRAnteris Technologies Global Corp. (AVR) is a medical device company specializing in the development and commercialization of advanced technologies for the treatment of cardiovascular diseases. It focuses on innovative solutions such as transcatheter aortic valve replacement (TAVR) systems designed to improve patient outcomes and procedural efficiency.
$4.71 +0.04 (0.86%)
Company News
Anteris Announces Results for the Third Quarter of 2025
Anteris Technologies received FDA approval to commence patient recruitment for its PARADIGM Trial, evaluating the DurAVR® Transcatheter Heart Valve across the United States, Europe, and Canada. The company advanced regulatory activities, strengthened operational systems, and reported $59.3 million in net operating cash outflows for the first nin...
